Need help finding what you are looking for?
Contact Us
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480536
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1480536
Neuroscience Antibodies and Assays
PUBLISHED:
PAGES: 179 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Global Neuroscience Antibodies and Assays Market to Reach $8.8 Billion by 2030
The global market for Neuroscience Antibodies and Assays estimated at US$4.8 Billion in the year 2023, is expected to reach US$8.8 Billion by 2030, growing at a CAGR of 8.9% over the period 2023-2030. Neuroscience Antibodies and Assays Consumables, one of the segments analyzed in the report, is expected to record 9.2% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Neuroscience Antibodies and Assays Instruments segment is estimated at 8.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 8.2% CAGR
The Neuroscience Antibodies and Assays market in the U.S. is estimated at US$1.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.
Introducing Our Exciting New Report Features for 2024
Full access to influencer engagement stats
Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
Complimentary report updates for one year
Competitor coverage with global market shares of major players
Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
Select Competitors (Total 11 Featured) -
- Abcam PLC
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- F. Hoffmann-La Roche AG
- GenScript Biotech Corporation
- Merck KgaA
- Rockland Immunochemicals, Inc.
- Santa Cruz Biotechnology, Inc.
- Siemens Healthineers
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.
Product Code: MCP13582
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Neuroscience Antibodies and Assays - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 16: World Neuroscience Antibodies and Assays Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Neuroscience Antibodies and Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Neuroscience Antibodies and Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Immunochemistry / Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Immunochemistry / Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Immunochemistry / Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 29: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 30: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
- UNITED STATES
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 35: USA Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: USA 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: USA 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- CANADA
- TABLE 41: Canada Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 42: Canada Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: Canada 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 44: Canada Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: Canada 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 47: Canada Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Canada 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- JAPAN
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 50: Japan Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: Japan Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: Japan 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 53: Japan Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: Japan 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Japan 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- CHINA
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 59: China Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: China Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: China 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 62: China Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: China Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: China 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 65: China Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: China Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: China 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- EUROPE
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 68: Europe Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: Europe Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: Europe 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 71: Europe Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: Europe 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Neuroscience Antibodies and Assays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Europe 16-Year Perspective for Neuroscience Antibodies and Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Europe 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- FRANCE
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 80: France Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: France Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: France 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 83: France Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: France Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: France 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 86: France Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: France Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: France 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- GERMANY
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 89: Germany Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: Germany Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Germany 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 92: Germany Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 94: Germany 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 95: Germany Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 97: Germany 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- ITALY
- TABLE 98: Italy Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 99: Italy Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 100: Italy 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 101: Italy Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 103: Italy 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 104: Italy Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 106: Italy 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- UNITED KINGDOM
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 107: UK Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 108: UK Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 109: UK 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 110: UK Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 112: UK 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 113: UK Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 115: UK 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- REST OF EUROPE
- TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 117: Rest of Europe Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 118: Rest of Europe 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 120: Rest of Europe Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 121: Rest of Europe 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 123: Rest of Europe Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 124: Rest of Europe 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- ASIA-PACIFIC
- Neuroscience Antibodies and Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 126: Asia-Pacific Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 127: Asia-Pacific 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 129: Asia-Pacific Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 130: Asia-Pacific 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 132: Asia-Pacific Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 133: Asia-Pacific 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
- REST OF WORLD
- TABLE 134: Rest of World Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 135: Rest of World Historic Review for Neuroscience Antibodies and Assays by Technology - Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 136: Rest of World 16-Year Perspective for Neuroscience Antibodies and Assays by Technology - Percentage Breakdown of Value Sales for Immunochemistry / Immunoassays, Molecular Diagnostics, Clinical Chemistry and Other Technologies for the Years 2014, 2024 & 2030
- TABLE 137: Rest of World Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 138: Rest of World Historic Review for Neuroscience Antibodies and Assays by End-Use - Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 139: Rest of World 16-Year Perspective for Neuroscience Antibodies and Assays by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes and Hospitals & Diagnostic Centers for the Years 2014, 2024 & 2030
- TABLE 140: Rest of World Recent Past, Current & Future Analysis for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 141: Rest of World Historic Review for Neuroscience Antibodies and Assays by Offering - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 142: Rest of World 16-Year Perspective for Neuroscience Antibodies and Assays by Offering - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
IV. COMPETITION
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.